INS and Hyperglycemia: They suggested that the development of hyperglycemia might be the consequence of increase fat level tissue resulting in decrease peripheral insulin sensitivity.70However, dietetic measures to restrict glucose exogenous uptake in patients who developed hyperglycemia were not successful,63and nilotinib does not induce changes in patient body weight.71Little is known regarding the mechanism by which nilotinib induces insulin resistance.